Polaris Market Research today announced findings from its latest report, projecting the global Intracranial Stenosis Stents Market to grow from USD 910.72 million in 2024 to USD 1,620.02 million by 2032, at a CAGR of 7.50%. The report profiles nine leading companies across two market segments, product and end use, along with regional coverage.

Analyst Commentary on Intracranial Stenosis Stents Market Growth

“A rising stroke burden, an ageing population and the shift to minimally invasive neurovascular procedures are driving market growth.” said an analyst at Polaris Market Research. “Opportunity is greatest for device makers expanding self-expanding and coil-support stent portfolios and building clinical access in Asia Pacific.”

Key Market Statistics at a Glance

•        2024 Market Size: USD 910.72 Million

•        2032 Projected Size: USD 1,620.02 Million

•        CAGR (2024-2032): 7.50%

•        Largest Region: North America

•        Fastest-Growing Region: Asia Pacific

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: The increasing incidence of stroke, rising demand for minimally invasive intracranial procedures, and a growing elderly population are the primary forces behind the market’s expansion, alongside growing demand for stent-assisted coiling. The World Stroke Organization reports more than 12.2 million new stroke cases globally each year. A shortage of trained neuro-interventionalists and high procedure costs remain restraints.

Major Companies Covered: Phenox, Medtronic, Acandis GmbH, MicroPort Scientific Corporation, MicroVention.

Segments Covered: By Product (Self-expanding Stents, Embolization Coil Support Intracranial Stents, Venous Sinus Stents, Balloon-expanding & Other Stents), By End Use (Hospitals, Ambulatory Surgical Centers, Others), By Region.

Read More @ https://www.polarismarketresearch.com/industry-analysis/intracranial-stenosis-stents-market

Recent Industry Developments

•        August 2022: MicroPort Scientific announced the first successful implantation of its NeuroTech APOLLO Intracranial Arterial Stent System in Brazil.

•        December 2020: MicroPort Scientific received China NMPA approval for its Bridge Drug-Eluting Stent, designed for symptomatic vertebral artery stenosis.

Regional Snapshot: North America Leads, Asia Pacific Fastest-Growing

North America led in 2022, supported by high rates of hypertension and stroke and well-established healthcare facilities. Asia Pacific is projected to register the fastest growth, backed by an ageing population, rising ischemic stroke incidence, improving healthcare infrastructure and growing awareness in India and China. Self-expanding stents held the largest share by product, and hospitals led by end use.

Why It Matters for Buyers and Investors in Neurovascular Devices

For stakeholders researching market share and key players, the underlying report benchmarks company positioning and segment-level market forecast data to support sourcing, partnership and investment decisions through 2032.

More Trending Latest Reports By Polaris Market Research:

mens-jewelry-market

offshore-support-vessel-market

car-t-cell-therapy-market

top-maleic-anhydride-manufacturers-and-key-insights-2024

top-10-electric-bike-sharing-services-companies-in-2025:-future-of-e-bikes-sharing

polyvinyl-chloride-pvc-market

cannabidiol-market

smart-home-energy-monitoring-devices-market

dental-loupe-market